Senior Associate Scientist, Discovery Science

Company Overview: FogPharma, a biopharmaceutical company based in Cambridge, Mass, is at the forefront of developing Helicon™ therapeutics - unique peptides that can enter cells efficiently and modulate protein interactions. They are revolutionizing medical treatment by targeting intracellular disease drivers previously untouched by existing drugs. With their leading product FOG-001 under evaluation in a Phase 1/2 study for advanced solid tumors, FogPharma is leveraging proprietary machine learning tools for discovery and development.

Job Role: FogPharma is looking for a detail-oriented candidate to join their Discovery Sciences group. This role involves analytical and purification tasks, analyzing compounds' properties, and ensuring high-quality outcomes with automated instrumentation. The successful candidate will collaborate closely with the purification group head, maintain lab systems, and contribute to the development of new compounds for therapeutic programs.

Qualifications: - Bachelor’s degree with 5+ years in pharmaceutical or biotech industry - Proficiency in UV-triggered/Mass-directed HPLC chromatography for peptide purification - Experience in physiochemical properties assessment, troubleshooting equipment, and solid-phase peptide synthesis knowledge is beneficial. - Strong analytical development, problem-solving, and communication skills - Ability to work independently, adapt to changing priorities, and excel in a fast-paced environment - Prior experience with Empower/Masslynx and HPLC analysis is preferred

Core Values: FogPharma values creativity, patient focus, execution-oriented mindset, and humility. They emphasize the importance of creating a supportive workplace and driving innovation for patient well-being. FogPharma is an equal opportunity employer that promotes diversity and inclusion in the workplace.

Location: 30 Acorn Park Drive, Cambridge, MA 02140

For more information, visit fogpharma.com.

About the Company
FogPharma Logo

Description: FogPharma was born from the scientific and entrepreneurial vision of founder Greg Verdine, a pioneer in the discovery and development of new drug classes that “drug the undruggable.” FogPharma’s cell-penetrating mini proteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics. Together with world-leading experts and collaborators in cancer biology and therapy, our team is building a drug discovery powerhouse having passion, knowledge, and creativity to develop fundamentally new cancer treatments. FogPharma derives financial support from a unique syndicate of extraordinary private and institutional investors. FogPharma’s network of friends includes our founders, employees, investors, advisors, collaborators, and cancer patients; all working together to pioneer a unique approach toward conquering cancer.

Industry: Health Tech

Company Size: Medium (51-250 employees, $10M-$50M revenue)

Visit Company Website

Actions
Apply Now